-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
10 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$58.00 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$9.42 M
Immunovant, Inc. Insider Transactions
Immunovant, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Levine Mark S.
Chief Legal Officer |
Sell | 2,358 @ $29.64 | $69,891 | 337,556 | 07/17/2024 | 07/19/2024 | |
|
Levine Mark S.
Chief Legal Officer |
Sell | 147 @ $30.55 | $4,491 | 337,409 | 07/17/2024 | 07/19/2024 | |
|
Macias William L.
Chief Medical Officer |
Sell | 2,362 @ $29.64 | $70,010 | 372,041 | 07/17/2024 | 07/19/2024 | |
|
Macias William L.
Chief Medical Officer |
Sell | 147 @ $30.55 | $4,491 | 371,894 | 07/17/2024 | 07/19/2024 | |
|
Macias William L.
Chief Medical Officer |
Sell | 504 @ $29.64 | $14,939 | 371,390 | 07/17/2024 | 07/19/2024 | |
|
Macias William L.
Chief Medical Officer |
Sell | 31 @ $30.55 | $947 | 371,359 | 07/17/2024 | 07/19/2024 | |
| Sell | 2,939 @ $29.64 | $87,112 | 347,728 | 07/17/2024 | 07/19/2024 | ||
| Sell | 184 @ $30.55 | $5,621 | 347,544 | 07/17/2024 | 07/19/2024 | ||
|
Butchko Julia G.
Chief Development Officer |
Sell | 2,698 @ $29.64 | $79,969 | 444,155 | 07/17/2024 | 07/19/2024 | |
|
Butchko Julia G.
Chief Development Officer |
Sell | 169 @ $30.55 | $5,163 | 443,986 | 07/17/2024 | 07/19/2024 | |
|
Salzmann Peter
CEO |
Sell | 8,175 @ $29.64 | $242,307 | 1,023,922 | 07/17/2024 | 07/19/2024 | |
|
Salzmann Peter
CEO |
Sell | 510 @ $30.55 | $15,581 | 1,023,412 | 07/17/2024 | 07/19/2024 | |
| Sell | 4,747 @ $28.06 | $133,201 | 350,667 | 07/09/2024 | 07/10/2024 | ||
|
Butchko Julia G.
Chief Development Officer |
Sell | 1,527 @ $28.06 | $42,848 | 446,853 | 07/09/2024 | 07/10/2024 | |
|
Salzmann Peter
CEO |
Sell | 4,619 @ $28.06 | $129,609 | 1,032,097 | 07/09/2024 | 07/10/2024 | |
| Sell | 4,042 @ $29.65 | $119,845 | 355,414 | 05/22/2024 | 05/24/2024 | ||
|
Salzmann Peter
CEO |
Sell | 16,163 @ $29.65 | $479,233 | 1,036,716 | 05/22/2024 | 05/24/2024 | |
|
Butchko Julia G.
Chief Development Officer |
Sell | 3,247 @ $29.65 | $96,274 | 448,380 | 05/22/2024 | 05/24/2024 | |
|
Macias William L.
Chief Medical Officer |
Sell | 3,247 @ $29.65 | $96,274 | 374,403 | 05/22/2024 | 05/24/2024 | |
|
Levine Mark S.
Chief Legal Officer |
Sell | 3,242 @ $29.65 | $96,125 | 339,914 | 05/22/2024 | 05/24/2024 |
Immunovant, Inc. Frequently Asked Questions
-
Who is on Immunovant, Inc.'s Insider Roster?
The list of insiders at Immunovant, Inc. includes Roivant Sciences Ltd., Salzmann Peter, Butchko Julia G., Barnett Eva Renee, Macias William L., Levine Mark S., MIGAUSKY GEORGE V, Pande Atul, Fromkin Andrew J., Geffner Michael, Stout Jay S.
-
How much insider selling is happening at Immunovant, Inc.?
Insiders have sold a total of 288,319 Immunovant, Inc. shares in the last 12 months for a total of 9.42 M sold.
-
Which Immunovant, Inc. insiders have been selling company stock?
The following insiders have sold Immunovant, Inc. shares in the last 12 months: Salzmann Peter ($3.36 M), Butchko Julia G. ($848,546), Barnett Eva Renee ($1.37 M), Macias William L. ($651,475), Levine Mark S. ($1.01 M), MIGAUSKY GEORGE V ($504,567), Pande Atul ($490,668), Fromkin Andrew J. ($490,697), Geffner Michael ($477,254), Stout Jay S ($209,207),
-
How much insider buying is happening at Immunovant, Inc.?
Insiders have purchased a total of 1.53 M Immunovant, Inc. shares in the last 12 months for a total of 58.00 M sold.
-
Which Immunovant, Inc. insiders have been buying company stock?
The following insiders have purchased Immunovant, Inc. shares in the last 12 months: Roivant Sciences Ltd. ($58.00 M),